Last checked at 
7 Jun 2023 09:34
The following amendment has been made to the 'Change of Registered Office' announcement released on7 June 2023 at 07:00:03 under RNS No 8659B;
'France House' has been corrected to read as 'Frances House'.
All other details remain unchanged.
The full amended text is shown below.
Syncona Limited
Change of Company's Registered Office
7 June 2023
Syncona Limited announces that with effect from 14 June 2023 the Company's registered office address will change to:
Frances House
PO Box 273
Sir William Place
St. Peter Port
Guernsey, GY1 3RD
Channel Islands
[ENDS]
Enquiries
Syncona Ltd
Annabel Clark
Tel: +44 (0) 20 3981 7940
About Syncona
Syncona's purpose is to invest to extend and enhance human life. We do this by creating and building companies to deliver transformational treatments to patients in areas of high unmet need.
Our strategy is to create, build and scale companies around exceptional science to create a diversified portfolio of 20-25 globally leading healthcare businesses, across development stage and therapeutic areas, for the benefit of all our stakeholders. We focus on developing treatments for patients by working in close partnership with world-class academic founders and management teams. Our balance sheet underpins our strategy enabling us to take a long-term view as we look to improve the lives of patients with no or poor treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders.
Copies of this press release and other corporate information can be found on the company website at: www.synconaltd.com